S1037 Certolizumab Pegol Demonstrates Efficacy in Maintaining Response and Remission in Patients With Active Crohn's Disease Regardless of Their Immunosuppressant Treatment Status at Entry to the PRECiSE 2 Study

✍ Scribed by Stefan Schreiber; Munaa Khaliq-Kareemi; Ian C. Lawrance; Ole O. Thomsen; Stephen B. Hanauer; Ralph Bloomfield; William J. Sandborn

• Book ID: 119431604
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 80 KB
• Volume: 138
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(10)60755-x